Theme: Theme : Advancements in Digestive Health: Exploring New Frontiers in Gastroenterology and Hepatology
Gastroenterology 2024
- About Conference
- Who Should Attend
- Why to Attend
- Participation Options and Benefits
- Session Track
- Market Analysis
The 24th International Conference on Gastroenterology and Hepatology will take put on September 19-20, 2024, in Paris, France. This regarded Gastroenterology and Hepatology Conference serves as a worldwide stage for healthcare experts, researchers, and scholastics to examine the most recent headways and patterns in the areas of gastroenterology and hepatology. Participants will have the opportunity to engage in a comprehensive program highlighting keynote discourses, entire sessions, workshops, and poster presentations.
The conference points to cultivate the trade of inventive investigate, clinical practices, and helpful techniques. Participants can anticipate to pick up bits of knowledge into different points such as liver illnesses, gastrointestinal clutters, symptomatic strategies, and rising medications. Organizing openings will flourish, permitting members to collaborate with peers, build up proficient connections, and share knowledge.
Hosted in the dynamic city of Paris, the conference too offers a special social involvement, combining logical investigation with the chance to appreciate the verifiable and creative treasures of the city. Whether you are a prepared master or an early-career analyst, this conference guarantees to be an enhancing and rousing occasion that contributes essentially to the progression of gastroenterology and hepatology.
The 24th International Conference on Gastroenterology and Hepatology is a prestigious event that attracts a diverse audience from the healthcare sector. Those who should attend include:
- Gastroenterologists
- Hepatologists
- Medical Researchers
- Clinicians
- Surgeons
- Pharmacologists
- Drug Developers
- Medical Students
- Public Health Officials
- Medical Device Manufacturers
- Equipment Manufacturers
- Academic Educators
- Clinical Educators
- Industry Consultants
- Healthcare Administrators
- Nutritionists
- Dietitians
- Radiologists
- Pathologists
- Epidemiologists
- Biotechnologists
- Pharmaceutical Representatives
- Policy Makers
- Patient Advocacy Groups
Attending a gastroenterology conference can offer numerous professional and personal benefits, including:
· Latest Research: Gain insights into cutting-edge research in gastroenterology and hepatology, presented by leading experts, to stay updated with the latest advancements in the field.
· Networking Opportunities: Connect with global professionals, fostering collaborations, mentorship, and career opportunities, enhancing your professional network and broadening your horizons.
· Innovative Technologies: Explore the newest diagnostic tools, medical devices, and treatments showcased by industry leaders, helping you integrate advanced technologies into your practice.
· CME Credits: Earn Continuing Medical Education credits to maintain your medical license and certification, ensuring compliance with professional development requirements while expanding your knowledge.
· Skill Enhancement: Participate in workshops and hands-on sessions to refine your clinical skills and techniques under the guidance of experienced practitioners and experts.
· Future Trends: Learn about emerging trends and future directions in gastroenterology and hepatology, preparing you to anticipate and adapt to changes in the field.
· Research Presentation: Present your own research, receive valuable feedback, and gain recognition from peers, potentially leading to publication opportunities and enhanced professional standing.
Participation Options:
Gastroenterology conference, provides the participants with different modes or ways to participate as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category. Mode of participation is Madrid, Spain through Power Point Presentation/ Video Presentation on Cisco Madrid, Spain.
- Keynote speaker: 45-50 minutes
- Speaker (oral presentation): 25-30 minutes (only one person can present)
- Speaker (workshop): 45-50 minutes (more than 1 can present)
- Speaker (special session): 45-50 minutes (more than 1 can present)
- Speaker (symposium): more than 45 minutes (more than 1 can present)
- Delegate(only registration): will have access to all the sessions with all the benefits of registration
- Poster presenter: can present a poster and enjoy the benefits of delegate
- Remote attendance: can participate via video presentation or e-poster presentation
- Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
- Media partner
- Sponsor
- Collaborator
Participation Benefits:
- Attend Keynote Presentation by world’s most eminent researchers
- Access to all the sessions
- Get Participation certificate
- Get worldwide acknowledgment to your profile and Research
- Get your abstracts published with unique DOI in International Journals
- Get up to 50% discounts for publishing your entire article in our open access International Journals
- Get Handbooks and conference kits
- Get an access to the network with eminent personalities from worldwide
- To learn and expand the knowledge from Top Gastroenterologist, Professionals
- Get your Abstract published and Certified for your participation
- Mark new links and trigger your profession
- Acquire a global exposure to your research idea
- The Gastroenterology conference cooperates with associates around the world who focused on learning concerning Gastroenterology and its specialties. This is often the best opportunity to reach the largest gathering participants. This event is recognized for distribution the data demonstrations, knowledge, information and B2B meetings with industrialists and prospective clients to form a splash with innovative products.
- Advantage from updates and bits of knowledge on the newest gastrologer procedure, and in addition recommendations for guaranteeing best practice and Potentiate results.
- Associate with 200+ amazing representatives who are included in Gastroenterology issue resolve shared difficulties and expansion from the broad familiarization of others.
- Attend a range of informative seminars, engaging interactive presentations, and keynote panel discussions with key policy manufactures and specialists in Gastroenterology conference
- Be the first to showcase your research, innovation, and brand to gain competitive advantages. Meet your target audience and explore your product and services.
Track 1 - Gastroenterology
Track 2 - Intestinal and Colorectal Disorders
Track 3- Diseases of the Esophagus
Track 4- Pathology of Gastrointestinal Bleeding
Track 5- Gallstones and Stones in the Bile Duct
Track 6- Viral Gastroenteritis and Gastrointestinal Infection
Track 8-Microbiome of the Gut
Inflammatory Bowel Disease (IBD) is an idiopathic illness caused by an anomalous resistant reaction to intestinal microflora. The two major sorts of IBD are ulcerative colitis (UC), which influences as it were the colonic mucosa, and Crohn's infection (CD), which influences any framework of the gastrointestinal tract from the mouth to the buttocks, incorporates "skip bruises," and is transmural. IBD has a innate inclination, and patients with this condition are more likely to create cancer.
Track 10- Advances in Gastrointestinal Endoscopy
Track 11- Gastroenterology, both diagnostic and therapeutic
Track 12- Gastrointestinal Imaging and Radiology
Track13-GI Oncology
Track 14-Medical Pharmacology of the Gastrointestinal
The most common gastroenterological transplants have involved the liver, pancreas, esophagus, small intestine, and colon. Since a transplant is a serious medical process, the peace must be observed during and after the procedure. The majority of the time, issues develop following surgery when the body starts to reject the joint or organ. The goal of a liver transplant is to remove the diseased or damaged liver and replace it with a whole modern solid liver or a portion of the liver from a different/healthy individual, known as a donor. People who have severe or ongoing liver failure require a liver transplant to survive.
Track 16- Primary & Abdominal Care
Discomfort beneath the rib cage and over the pelvic zone is commonly alluded to as stomach torment or a stomach hurt. Stomach torment may result from an aggravation that influences the pancreas, liver, gallbladder, kidneys, little or expansive guts, reference section, spleen, stomach, or gallbladder. Viral, bacterial, or parasite diseases that influence the insides and stomach can result in agonizing stomach torment. Stomach inconvenience is ordinarily analyzed by your essential care doctor after analyzing your physical indications and pointers. Treatment for stomach torment depends on the potential basic causes of the torment, the patient's age, and therapeutic history.
Track 17- Advanced in Hepatology
The consider, anticipation, investigation, and treatment of diseases that influence the pancreas, gallbladder, liver, and biliary frameworks are the center of the restorative field known as hepatology. Hepatitis C infection disease will no longer be an issue in the future of hepatology; a diverse issue has developed. Hepatitis C infection is no longer the most common cause of incessant liver sicknesses in western countries; instep, weight, metabolic clutters, and related non-alcoholic greasy liver maladies have taken its put. Atomic science, medications, imaging, and surgery have made unimaginable strides that have enormously helped our understanding and capacity to treat children with liver issues. There is as of now no upper age or weight constrain for beneficiaries of liver transplants much obliged to surgical breakthroughs.
Track 18- Liver diseases and Hepatitis
The stomach and gastrointestinal tract are two major subjects in gastrointestinal surgery. The administration of the central apprehensive framework, immunology, centered care, absorption, neoplasia, nourishment, pathology, physiology, stun and restoration, and wound mending are all assignments performed by common pros. Advanced negligibly obtrusive surgery, which can join robotic-assisted strategies, calls for millimeter-long entry points. The modest cuts make a path for specialized surgical apparatuses and a laparoscope, a fiber-optic gear that is embedded into the guts divider. The less intrusive strategy has benefits like faster recuperation times, shorter healing center remains, and less blood misfortune after surgery.
Track23-Bariatric surgery and obesity
Track 24 - Motility and Neurogastroenterology
Track 25- Dietetics in Gastroenterology and Nutrition
Gastrointestinal Therapeutics Market
The gastrointestinal therapeutics market is expected to register a healthy CAGR of nearly 6.5 % during the forecast period (2019 - 2024). According to market research, North America had the largest global revenue for gastrointestinal drugs in 2016 with a total of 17,288 US dollars million, whereas the Middle East and Africa continent had a low revenue creation rate. A CAGR of 3.5 percent is predicted for the market for prescription medicines, taking it from $18.6 billion in 2016 to roughly $22.1 billion in 2021. (approx.). With a CAGR of 5.9% from 2017 to 2021, the global diagnostics market will increase from $17.7 billion in 2019 to $23.5 billion in 2022.
According to market research, North America had the largest global revenue for gastrointestinal drugs in 2016 with a total of 17,288 US dollars million, whereas the Middle East and Africa continent had a low revenue creation rate. A CAGR of 3.5 percent is predicted for the market for prescription medicines, taking it from $18.6 billion in 2016 to roughly $22.1 billion in 2021. (approx.). With a CAGR of 5.9% from 2017 to 2021, the global diagnostics market will increase from $17.7 billion in 2019 to $23.5 billion in 2022.
By 2020, the market for gastrointestinal treatments is anticipated to grow to a value of around USD 13.8 billion, with a CAGR of 6.5 percent from 2016 to 2020. This increase in market size is attributable to a number of factors, including rising biologics consumption, preliminary approval of late-stage molecules, development of medicines using cutting-edge technology, and an increase in the population seeking treatment.
Inflammatory Ulcerative Colitis Holds Significant Market Share
The condition known as inflammatory ulcerative colitis (UC) frequently recurs. Lifelong therapy is frequently used to treat the condition. The present therapy choices, however, have a number of negative side effects and subpar efficacy characteristics. Additionally, the drug might be very expensive in some cases, which makes this market profitable for the biopharmaceutical companies. Inflammatory bowel illness can benefit from some conventional therapeutic types, such as corticosteroids, 5-aminosalicylic acid, and immune-modulating medicines (IBD). Several biologic medications, including anti-TNF medications, immunosuppressive interleukins, and anti-interleukin antibodies, have been approved for use in recent years. Merck & Co. Inc. (2018) reports that, despite the availability of a variety of pharmaceutical options, one-third of all UC patients ultimately need surgery.
Top companies:
Associations and Societies of Gastroenterology
Conference Highlights
- Gastroenterology
- Intestinal and Colorectal Disorders
- Diseases of the Esophagus
- Pathology of Gastrointestinal Bleeding
- Gallstones and Stones in the Bile Duct
- Viral Gastroenteritis and Gastrointestinal Infection
- Gastroparesis
- Microbiome of the Gut
- IBD (Inflammatory Bowel Disease)
- Advances in Gastrointestinal Endoscopy
- Gastroenterology, both diagnostic and therapeutic
- Gastrointestinal Imaging and Radiology
- GI Oncology
- Medical Pharmacology of the Gastrointestinal
- Transplants for gastrointestinal conditions
- Primary & Abdominal Care
- Advanced in Hepatology
- Liver diseases and Hepatitis
- Pregnancy and Gastroenterology
- Pancreatic Cancer and Tumor
- Hepato-pancreato-biliary disease
- Minimally Invasive Surgery and Gastrointestinal
- Bariatric surgery and obesity
- Motility and Neurogastroenterology
- Dietetics in Gastroenterology and Nutrition
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | September 19-20, 2024 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | |||
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
- ISSN: 2161-069X Journal of Gastrointestinal & Digestive System
- Journal of Hepatitis
- Research and Reports in Gastroenterology
Abstracts will be provided with Digital Object Identifier by